ArticleComprehensive physiology2025
Interorgan Communication Between Lung and Colorectal Epithelial Cells Studied Using a Novel Multi-Organ-On-Chip System.
Article in Comprehensive physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Endodermal Organoids Along Two Axes: Single-Organ Fidelity, Inter-Organ Reconstruction, and the Unbuilt Gut-Lung Frontier.Stem cell reviews and reports · 2026Review
- Autophagy as a Redox Rheostat Linking Cigarette Smoke, Electronic Cigarettes, and Nicotine Exposure to Lung Development, Disease, and Interorgan Communication.Comprehensive physiology · 2026Review
- Respiratory Organ-on-a-Chip for Disease Modeling: From Architecture to Functional Integration.Advanced healthcare materials · 2026Review
- Application and prospects of organoid-on-a-chip in research on the intestinal mucosal barrier.Burns & trauma · 2026Review
- Interorgan Communication Between Lung and Colorectal Epithelial Cells Studied Using a Novel Multi-Organ-On-Chip System.Comprehensive physiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Chronic Obstructive Pulmonary Disease (COPD), a severe lung disease caused by chronic inhalation of toxic gases and particles, is often accompanied by extrapulmonary comorbidities. These are characterized by systemic inflammation and activation of the bi-directional lung-gut axis, in which communication takes place between lung and intestinal cells. The mechanisms of interorgan communication in COPD are largely unknown, partly due to the lack of suitable in vitro models to study interorgan communication. In the current study, we developed a novel unidirectional millifluidic multi-organ-on-chip (MOoC) device, in which stimulated lung epithelial cells were connected to colorectal cells. Human lung epithelial A549 cells were exposed to cigarette smoke extract and nylon microplastic fibers, mimicking inhaled pollutants that induce lung epithelial damage and can contribute to the development of COPD. Once exposed, A549 cells were connected to naïve colorectal DLD-1 cells within our MOoC system to study interorgan communication mediated by released factors such as cytokines, chemokines, or Damage Associated Molecular Patterns (DAMPs). A549 cells treated with inhalable pollutants released communication mediators, such as the DAMP galectin-3. Naïve DLD-1 cells responded to these released factors from stimulated A549 cells by inducing pro-inflammatory responses, demonstrated by increased IL-6 mRNA expression and decreasing barrier integrity, as demonstrated by decreased CDH1 mRNA expression and delocalization from the cell membrane of E-cadherin and ZO-1 proteins. This study introduces a novel chip platform that can be used to study communication between cells derived from different organs. This study also provides relevant insight into the mediators involved in lung-gut axis communication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.